Home Tags United States

Tag: United States

Jefferson launches the nation’s only university-based cannabis science graduate certificate programs

7/5/18--The Lambert Center for the Study of Medicinal Cannabis and Hemp at Thomas Jefferson University has created the nation’s first—and only—university-based, graduate-level certificates in cannabis education for healthcare and industry professionals. This fall, The Lambert Center will launch graduate certificates in Cannabis Medicine and Cannabinoid Pharmacology, both the first of their kind. In 2019, the Cannabinoid Chemistry and Toxicology Graduate Certificate will be launched. Read

Medical marijuana a hit with seniors

7/5/18--Seniors are giving rave reviews for medical marijuana. In a new survey, those who turned to it for treating chronic pain reported it reduced pain and decreased the need for opiod painkillers. Nine out of 10 liked it so much they said they'd recommend medical pot to others. Read

Netflix’s Marijuana Show ‘Cooking on High’ Draws Jeers

7/5/18--Netflix has hit a low note with “Cooking on High.” The food series, in which competitors cook marijuana-infused dishes for a pair of judges, has been panned by viewers and critics alike. One Washington Post review slammed ineptitude among the show’s judges. Read

FDA rejects petition to further restrict marijuana

7/5/18--The U.S. Food and Drug Administration (FDA) has denied a request from an anti-legalization group to place marijuana and its derivatives on a list of restricted substances that are not "generally recognized as safe and effective." The move is "not necessary for the protection of public health," Janet Woodcock, the director of FDA's Center for Drug Evaluation and research wrote on Monday in a letter to the group, Drug Watch International. Read

Colorado company changing name to add ‘hemp,’ remove ‘pot’

7/3/18--PotNetwork Holdings, a Colorado CBD maker, is changing its name to to BioTech Hemp to take the word “pot” out of its title and add “hemp.” The company, which owns the brand Diamond CBD, said the change “underscores the company’s strengthening identity as a dominant player in the CBD industry.” Read

In major study, cannabis shows no benefit for chronic pain

7/3/18--Cannabis' medical benefits have suffered a serious blow, with a major study finding it does almost nothing to help people with chronic pain. The study, one of the largest and most in depth ever done on the drug’s medical use, found cannabis does not cut pain, nor does it help sufferers replace opioids. And users seem to suffer higher levels of anxiety overall. Read

Here’s how California might enforce violations of marijuana business rules

7/3/18--For now, regulators say they plan to maintain a softer approach to enforcement instead of immediate crackdowns in which fines are levied on companies that don’t heed the law. The Bureau of Cannabis Control, which oversees retailers, distributors, testing labs, and microbusinesses, will likely run point on inspections and enforcement, although the DFA oversees growers and the DPH governs edibles makers and concentrate producers. The strongest enforcement actions will likely be reserved for repeat violators. Read

Mr. Trump, please don’t legalize marijuana at the federal level

7/3/18--President Trump has spoken out forcefully about defeating the illegal drug problem. Now he is urged to support marijuana legalization in the midst of the most deadly drug abuse epidemic in American history. Ex-drug czars Bill Bennett and John Walters firmly believe that the President should forcefully reject marijuana legalization, and direct his staff to get the facts out and push back against the ignorance that risks turning our drug policy into one of the worst self-inflicted wounds in American history. Read

Marijuana use associated with respiratory issues

7/2/18--Individuals who smoke marijuana regularly are likely to experience cough, increased sputum production and wheezing, according to a study published in Annals of Internal Medicine. Read

Even once-a-week pot smokers have more cough, phlegm

7/2/18--Smoking marijuana once a week can cause coughing, wheezing and phlegm, all signs of chronic bronchitis, a new evidence review reports. Pot smoking doubles a person's risk of developing a regular hacking cough. It also triples the risk of coughing up phlegm and suffering from wheezy constricted breathing, researchers found. Dr. Norman Edelman, senior scientific adviser to the American Lung Association, said he's concerned that heavy marijuana use could lead to larger health problems for those who develop chronic bronchitis. Read

Are there risks from secondhand marijuana smoke? Early science says yes

3/19/18--Scientists are finding that, just as with secondhand smoke from tobacco, inhaling secondhand smoke from marijuana can make it harder for arteries to expand to allow a healthy flow of blood. Read

Home Depot now selling American Cannabis Company products online

3/15/18--The Home Depot Inc. has planted a partnership seed with the cannabis industry. The Atlanta-based retail giant joined Walmart Inc. and Amazon Inc. in securing online distribution channels with American Cannabis Company Inc., a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry. Read

House of Medicine opens the door to addiction prevention & treatment

3/15/18--Two landmark developments in medicine pave the way for quality medical care to address America's largest and most costly preventable health problem - unhealthy substance use and addiction involving all addictive substances. These changes are designed to increase the number of addiction medicine physician specialists who can provide direct patient care and consultation, teach other providers and thereby drive knowledge across health care, and help policymakers and the public understand and effectively respond to our current health crisis. Read

Changing marijuana laws and the opioid crisis are prompting employer action

3/13/18--While CEOs still tend to opt for termination over rehabilitation for drug use, the reality is that employers may not be able to afford to do so while recruitment and retention remain a key HR concern. If an HR manager hasn’t dealt with a drug issue at their workplace yet, its likely they will very soon. HR will need to align with employee assistance programs (EAPs) and with workers’ comp providers to lessen the use of opioids and get provider buy-in for the anti-opioid direction. Read

Charlotte’s Web’s secrets revealed as parent company plans to go public in Canada

6/29/18--Stanley Brothers Holdings plans to go public in Canada, the latest in a growing list of U.S. businesses looking north of the border to raise capital. The firm is the parent company of CW Hemp, the manufacturer of Charlotte’s Web CBD products, that was catapulted into the media spotlight in 2013 when it was featured in the CNN documentary “Weed.” According to the firm’s preliminary prospectus Stanley Brothers, the company has been steadily posting an annual profit since 2016. Read

Mitch McConnell: Drug warrior, CBD champion?

6/29/18--The Senate passed a version of the 2018 Farm Bill that would legalize so-called “industrial hemp” – legislation that has long been a pet project of Senate Majority Leader Mitch McConnell (R-KY). McConnell has been pushing the point that hemp is “a completely different plant than its illicit cousin,” marijuana, and that Americans are clamoring for more hemp products, spending $820 million last year on “everything from clothing to auto parts,” mostly made out of hemp grown overseas. Read

Ricki Lake-produced film Weed the People argues for marijuana use as a cancer treatment

3/10/18--As marijuana use continues to become decriminalized across the United States, doctors, researchers and patients are pushing to make it an accepted part of cancer treatments. The new film Weed the People, executive-produced by Ricki Lake, follows families as they discover the benefits of marijuana for their child’s cancer and chemotherapy. Read

Hot ink: CBD makers hoping tattoo-care products will open new $1.6 billion market

3/6/18--A growing number of hemp companies are launching products aimed at the tattoo industry, from CBD patches marketed as pain relief to balms and creams designed to speed recovery, to expand their retail opportunities. The trend comes as CBD producers look for non-marijuana retail opportunities amid ongoing legal uncertainty about cannabis’ legal status. Read

New studies show that legal cannabis access reduces opioid abuse

3/4/18--Scientific data is growing nearly by the day in support of the notion that legalized cannabis can mitigate opioid use and abuse. For instance, among states where medical cannabis access is permitted, patients routinely lessen their opioid intake. According to data published this week by the Minnesota Department of Health, among those patients known to be taking opiate painkillers upon their enrollment into the program, 63 percent “were able to reduce or eliminate opioid usage after six months.” Read

Increasing study data indicates medical cannabis Can reduce opioid use, deaths

3/4/18--Libertarian think tank The Cato Institute last week posted an article citing a study report issued by the Minnesota Department of Health. Study results, which surveyed data from 2,000 first-time medical marijuana users with intractable pain, said 42 percent of those patients reported a 30 percent decrease or more in their level of pain. Perhaps, more importantly, the study also found that of those patients taking opioid medications for pain, 63 percent were able to reduce or curtail their opioid use, once treated with medical cannabis. Read

Federal health official says “There is no such thing as medical marijuana”

3/5/18--As health officials, law enforcement, and politicians carve a path forward through interdiction, treatment, and opioid alternatives, U.S. Secretary of Health and Human Services (HHS) Alex Azar has already dismissed medical cannabis as an option, even in the face of continued research showing the controversial plant's immense ability to wean users off pain pills and heroin. According to Azar, there is no such thing as medical marijuana, and there is no FDA approved use of marijuana. Read

Legalized medical marijuana doesn’t cause more teens to smoke weed, study finds

3/5/18--According to a study out of Columbia University, teen usage of cannabis neither increased nor decreased after states legalized pot use for medical problems. The study was an analytical examination of four separate national surveys with data from eleven separate studies dating back to 1991. Still, the researchers want to study adult cannabis use next, pointing to the possibility that while connections to teen abuse appear unlikely, there may be a link to people becoming more dependent on the drug in adulthood. Read

How does resolving cannabis problems differ from problems with alcohol or other drugs?

3/5/18--Individuals who report having resolved a problem with cannabis use appear to have done so at younger ages than those who resolved problems with alcohol or other drugs and were less likely to use any formal sources of assistance or support, report investigators from the Recovery Research Institute at Massachusetts General Hospital (MGH). Read

Why the FDA is high on a marijuana drug

6/29/18--The U.S. Food and Drug Administration approved a prescription drug for children with severe epilepsy on June 25, making it the first prescription medicine derived from cannabis permitted to be sold in the U.S. The decision is a boost for the U.K.’s biotech industry and bolsters the nation’s position, according to the United Nations, as the biggest producer of cannabis for medical and scientific purposes. Read

Where pedestrian deaths are up, is marijuana to blame?

2/28/18--Pedestrian deaths in traffic accidents have reached levels not seen in years, and a safety group has sought to explain why. It has identified several possible causes, like digital distractions and an increase in driving. Now it has added another: marijuana. Read

National marijuana survey plan announced by Massachusetts consultant and UMass-Dartmouth

6/29/18--The Cannabis Community Care and Research Network of Somerville said it will work with the University of Massachusetts in Dartmouth to mount a national survey of marijuana use. "The survey is aimed to better understand consumer/patient demographics, attitudes, choices, methods of consumption, and knowledge of cannabis products in legal cannabis states," a press release said. The plan for the survey was approved by the institutional review board of UMass-Dartmouth, and findings are to be published in a peer-reviewed journal and provided at conferences and forums. Read

Elizabeth Warren’s faulty claim about marijuana convictions

6/29/17--Making the case for criminal justice reform, Warren claimed that the United States locks up more people for “low-level offenses on marijuana” than for all violent crimes. As reported by The Washington Post's The Fact Checker, most crimes are prosecuted by state and local authorities, not the federal government. Furthermore, nearly 44,700 people at the state level were serving a sentence of one year or longer at the end of 2015 after being convicted of drug possession as their most serious offense, according to the Bureau of Justice Statistics. This includes not only marijuana but also heroin, cocaine, and other illicit drugs. Read  

Cronos, a marijuana producer, starts trading on the Nasdaq

2/27/18--Canadian marijuana producer Cronos Group is the first pot producer and seller to trade on Wall Street. Although other companies with indirect relations to cannabis are trading, this marks a big step for the cannabis industry. Read

D.A.R.E. programs unsure of how to teach marijuana in legalized states

2/25/18--As more states legalize cannabis for both medical and recreational use, anti-drug education programs struggle to stay relevant. Particularly, Drug Abuse Resistance Education (D.A.R.E.)—a popular school program created in 1983 by the Los Angeles Police Department—isn't sure how to adapt to new, sensible drug policies across the United States. Read

Cannabis descheduling not one of pharma giant’s “core priorities”

2/23/18--Indianapolis-based Eli Lilly & Co., a pharmaceutical giant that once developed marijuana-based medicines, won’t be advocating for the descheduling of cannabis anytime soon. The company opposes a shareholder proposal seeking Lilly to proclaim support of marijuana descheduling, according to a U.S. Securities and Exchange Commission filing made Friday. Read

The best marijuana gadgets for the tech-y stoner in your life

2/25/18--Silicon Valley is no stranger to cannabis culture, so it's no surprise that tech companies are driving innovation in the pot world with some seriously impressive products. From edibles to vapes, cultivation boxes to dab rigs, there are seemingly endless ways to consume cannabis in the growing number of states that have passed legislature legalizing marijuana. Read

Why is it so hard to dose weed

2/26/18--It's difficult to quantify just how much marijuana is being inhaled —especially because marijuana contains some 500 chemicals that interact in ways scientists are just beginning to understand. Science has more to learn about how marijuana works on the human body, and companies making cannabis devices are figuring out ways to tackle the dosing problem. Read

After legalization, Dr. Dre’s ‘Weed Man’ is thriving

2/22/18--Virgil Grant straddles two eras, the criminal past and the legalized future. Grant spent more than eight years in federal and state prisons for marijuana dealings, but now he is thriving in a multibillion-dollar marijuana industry with three licensed cannabis businesses in Los Angeles and several hip-hop stars as customers. Read

Experts challenge claims about medical marijuana’s impact on teen recreational use and opioid deaths

2/22/18--Two papers published today look at the current evidence of the effects of medical marijuana laws and conclude there is little support that such laws increase recreational marijuana use among adolescents or reduce opioid overdose deaths. Read

Trump administration cautions against hemp expansion

2/21/18--The Trump administration doesn’t want to see hemp expanded nationwide in the next Farm Bill because of concerns about overproduction, according to an official. Greg Ibach, undersecretary for the U.S. Department of Agriculture, said current hemp regulations are “fairly narrow” and that the Trump administration doesn’t necessarily want to see that change when the Farm Bill is rewritten this year. Read

One of the world’s largest tobacco giants is teaming up with Snoop Dogg’s VC firm to invest in medical cannabis research

6/28/18--Imperial Brands, one of the world's largest tobacco companies, is getting into cannabis through its venture arm in a Series A fundraising round for Oxford Cannabinoid Technologies (OCT). Snoop Dogg's cannabis-focused venture firm, Casa Verde Capital, also participated in the round. Read

Schumer introduces Marijuana Freedom and Opportunity Act

6/27/18--Senate Democratic Leader Chuck Schumer (D-NY) formally introduced new legislation to decriminalize marijuana at the federal level. Specifically, the Marijuana Freedom and Opportunity Act removes marijuana from the list of scheduled substances under the Controlled Substances Act, effectively decriminalizing it at the federal level. Read

Judge allows hemp oil seller’s defamation suit to continue

6/15/18--U.S. District Judge John Steele will allow a hemp oil company’s defamation suit to continue against a Florida doctor interviewed by a local TV news station. The federal judge denied Dr. Joseph Dorn’s request to dismiss the lawsuit filed by AFI Holdings of Illinois last year over the doctor’s comments to a reporter about a hemp oil product. Read

6 ways to beat a local cannabis ban

2/1/18--Retail cannabis may be legal statewide, but California law allows local municipalities to severely limit or ban cannabis companies. In many cases, bans were the response to the vocal outcry of a relatively small number of concerned citizens. However, bans can be reversed. Leafly presents a few ways to change votes. Read

Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease

1/17/18--A study revealed that among alcohol users, individuals who additionally use cannabis (dependent and non‐dependent cannabis use) showed significantly lower odds of developing alcoholic steatosis (AS), steatohepatitis (AH), fibrosis, cirrhosis (AC) and hepatocellular carcinoma (HCC). Additionally, findings suggest that cannabis use is associated with a reduced incidence of liver disease in alcoholics. Read

It’s high time for restaurants to pay attention to marijuana

2/1/18--Marijuana has the ability to impact nearly every aspect of the food world. From restaurant brands reaching their cannabis-friendly customers on social media to THC-laced concoctions competing with established restaurants. But, while more than half the country approves of legalization in some form, there’s still concern from retailers about alienating the rest of the population or stumbling into a legal gray area. Read

As states legalize marijuana, investors see an opportunity

1/26/18--Twenty-nine states now allow marijuana for medical purposes, while eight have legalized its recreational use. As the acceptance of marijuana is growing, so are the opportunities to invest in it. Investors put $500 million into private cannabis companies last year, said Troy Dayton, the chief executive and a co-founder of Arcview, which also has an investment arm. Read

Vaping can be addictive and may lure teenagers to smoking, science panel concludes

1/23/18--A national panel of public health experts concluded in a report released on Tuesday that vaping with e-cigarettes that contain nicotine can be addictive and that teenagers who use the devices may be at higher risk of smoking. Whether teenage use of e-cigarettes leads to conventional smoking has been intensely debated in the United States and elsewhere. Read

Marijuana money increasingly flowing to Republican lawmakers

1/21/18--Marijuana business owners are increasingly pouring their profits into lobbying lawmakers as they face a federal crackdown from the Trump administration. A USA Today survey found hundreds of thousands of dollars flowing from the cannabis industry into campaign finance accounts of both lawmakers and political action committees, with emphasis this year on Congressional Republicans who are trying to stop the Trump administration from targeting marijuana businesses. Read

Did my brother’s teen pot use lead to his schizophrenia?

1/19/18--Because pot is being legalized in more and more states, many young people assume it must be safe. However, when used by people whose brains are still developing (up to age 25), there is an increased risk of developing a mental illness. Recent studies have shown this vulnerability. Not everyone who smokes pot will become psychotic, but it is not harmless. Kids need to be warned about the huge risks associated with teen marijuana use. Read

Cigarettes and pot linked to teen psychosis

1/19/18--For teens, using either marijuana or cigarettes is associated with higher odds of psychotic-like experiences, a new study published Wednesday in the journal JAMA Psychiatry found. Psychosis describes the mental condition of losing touch with reality, such as experiencing hallucinations or delusions. Read

Jeff Sessions struggles to get planned marijuana crackdown going

6/10/18--Attorney General Jeff Sessions vowed to use federal law to get tough on marijuana, announcing in January he was ending Obama-era protections for the nascent pot industry in states where it is legal. Six months into his mission, he is largely going it alone. In fact, Mr. Sessions’ own prosecutors have yet to bring federal charges against pot businesses that are abiding by state law. Read

Pot peddlers are declaring war on booze

1/15/18--Marijuana boosters have declared war on booze. The number of billboards and other advertisements aimed at converting drinkers into tokers or nibblers of edible marijuana has exploded over the past several years. Read

Marijuana stocks rallied in December

1/11/18--Marijuana stocks continued the November rally into December as investors loaded up on stocks ahead of California’s legalized recreational sales. The U.S. Marijuana Index jumped 50% and the Canadian Marijuana Index climbed 65% for the month of December. Read

Hemp industry loses case against US drug enforcement agency

5/3/18--A federal appeals court sided with the Drug Enforcement Administration and upheld its decision that CBD is a Schedule 1 controlled substance — a major setback for the American hemp industry. The decision, issued Monday by a three-judge panel of the 9th Circuit in San Francisco, means that hemp producers can only sell cannabidiol where it is allowed under state law. Read

Democrats must seize on Jeff Sessions’ misguided marijuana policy

12/7/17--Despite Attorney General Jeff Sessions' focus on re-criminalizing, legalization activists are celebrating the widespread adoption of new marijuana laws. But, if history is any guide, declarations of legal marijuana’s permanence may be premature, according to Emily Dufton, author of Grass Roots: The Fall and Rise of Marijuana in America. Still, America’s previous experiments with both legalization and criminalization can provide clues for how to handle the country’s newest legal shift. Read

CNN reporter holds joints, lights bong for pot smoker on live New Year’s Eve broadcast

1/2/18--CNN reporter Randi Kaye, sporting large marijuana leaf styled earrings, lit a bong for a pot smoker during a live report from Denver broadcast on CNN’s New Year’s Eve show Sunday night that was hosted from Times Square by Anderson Cooper and Andy Cohen. Read

China says marijuana legalization to blame for US opioid crisis

12/28/17--According to Yu Haibin of the China National Narcotics Control Commission, the United States should look within to cut down demand for opioids which are fueling its deadly drug crisis rather than stressing unsubstantiated claims that China is the major source of these chemicals. Read

New SBA lending rules could curb loans to marijuana and hemp businesses

5/1/18--The U.S. Small Business Administration updated its lending guidelines with new rules that could have a major impact on businesses servicing the marijuana and hemp industries – not just plant-touching companies. The revised guidance, published in early April, prohibits banks from issuing SBA-backed loans to any company that has a direct business relationship with a cannabis or hemp business. Read

Several states likely to legalize marijuana in 2018

12/28/18--It was a big year for pot in 2017: For the first time, a majority of Americans said it should be legalized, four state ballot initiatives passed and startups pounced on California's approval of recreational use. The year ahead portends legalization in three states, and the first pro-pot initiatives enacted by lawmakers instead of voter referendums. Read

A doctor reveals exactly how to use cannabis for anxiety

1/7/2018--According to Dr. Jordan Tishler, MD, a Harvard-trained physician and the president of both InhaleMD and the Association of Cannabis Specialists, in order to avoid the intoxication effects of cannabis while benefiting from its antianxiety and antidepressant effects, it should be used at bedtime. Even though the intoxication wears off overnight, the antianxiety and antidepressant benefits last throughout the next day. Read

The top 10 cannabis lifestyle trends of 2017

12/28/17--This article presents the monumental strides and 10 key cannabis lifestyle trends that defined the past year. Read

FDA accepts GW Pharma’s NDA filing for Epidiolex in the treatment of LGS and Dravet syndrome

12/28/17--GW Pharmaceuticals (NASDAQ:GWPH) announces that the FDA has accepted for filing with Priority Review its recently submitted New Drug Application (NDA) for Epidiolex (cannabidiol or CBD), an investigational treatment for seizures associated with Lennox-Gastaut syndrome (LGS) and Dravet syndrome, two rare and difficult to treat conditions of childhood-onset epilepsy. The Prescription Drug User Fee Act goal date for completion of the FDA review of the Epidiolex NDA is June 27, 2018. Read

More pregnant women are using pot, study finds

12/26/17--More pregnant women seem to be using pot -- sometimes to ease the nausea of morning sickness or heightened anxiety -- and a new study suggests that this slight rise in marijuana use is most pronounced among those younger in age. Read

Gogek: Marijuana not the answer to opioids

12/18/17--According to Dr. Ed Gogek, a psychiatrist specializing in substance abuse, the marijuana industry wants us to believe pot can solve the opioid crisis, but if that were true opioid-related deaths would have steadily decreased after Arizona’s medical marijuana law took effect in 2011, and they didn’t. Before the law passed, the opioid death rate in Arizona was falling, and after the law kicked in, that changed. Between 2012 and 2016, opioid deaths increased by 74.6 percent. In other words, marijuana is not saving us from the opioid epidemic. Read